Syndax Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.About SNDX
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES.
CEOMichael A. Metzger
CEOMichael A. Metzger
Employees270
Employees270
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2005
Founded2005
Employees270
Employees270
SNDX Key Statistics
Market cap1.83B
Market cap1.83B
Price-Earnings ratio-5.81
Price-Earnings ratio-5.81
Dividend yield—
Dividend yield—
Average volume1.26M
Average volume1.26M
High today$21.80
High today$21.80
Low today$20.82
Low today$20.82
Open price$21.38
Open price$21.38
Volume1.04M
Volume1.04M
52 Week high$22.73
52 Week high$22.73
52 Week low$8.58
52 Week low$8.58
Stock Snapshot
The current Syndax Pharmaceuticals(SNDX) stock price is $21.27, with a market capitalization of 1.83B. The stock trades at a price-to-earnings (P/E) ratio of -5.81.
As of 2026-01-11, Syndax Pharmaceuticals(SNDX) stock has fluctuated between $20.82 and $21.80. The current price stands at $21.27, placing the stock +2.2% above today's low and -2.5% off the high.
The Syndax Pharmaceuticals(SNDX)'s current trading volume is 1.04M, compared to an average daily volume of 1.26M.
In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $22.73 and a 52-week low of $8.58.
In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $22.73 and a 52-week low of $8.58.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.